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 CURRENTOPINION Intestinal dysbiosis and innate immune responses
in axial spondyloarthritis
Francesco Ciccia, Angelo Ferrante, and Giovanni Triolo
Purpose of review
Inflammatory innate and adaptive immune cell responses to commensal bacteria underlie the pathogenesis
of human chronic inflammatory diseases. Intestinal dysbiosis has been described in patients with
spondyloarthritis (SpA) and seems to be correlated with histologic and immunologic alterations. Purpose of
this review is to discuss the relationship occurring between intestinal dysbiosis and innate immune
responses in patients with axial SpA.
Recent findings
Intestinal dysbiosis and differential activation of intestinal immune responses in patients with SpA have
been demonstrated. Furthermore, innate cells that appear to be involved in the pathogenesis of SpA may
control intestinal homeostasis through induction of apoptotic cell death and deletion of activated
commensal bacteria-specific T cells.
Summary
Although the evidence shows that dysbiosis occurs in SpA, it is not clear the role of dysbiosis in regulating
innate immune responses in SpA. Relationships between cause and effect remain to be answered.
Video abstract
http://links.lww.com/COR/A34.
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INTRODUCTION
Complex communities of microorganisms, termed
‘microbiota’, regulating host nutrient metabolism,
immune cell homeostasis, and also protecting from
pathogen infection, colonize the mammalian
gastrointestinal tract [1
&&
]. The communities of bac-
teria, essentially located in the lower intestine, are
separated from body tissues by the epithelial layer.
The invasion of host tissue by resident bacteria may
induce inflammation and sepsis. This is prevented
by the intestinal immune system, including epi-
thelial cells, that acts by complex interactions
between the host and the microorganisms preserv-
ing this symbiotic relationship [2].
Intestinal dysbiosis has been demonstrated in
the gut of patients with spondyloarthritis (SpA)
[3
&
,4
&
,5,6
&&
] and it is accompanied by differential
activation of Paneth cells (specialized cells in the
epithelium of the small intestine) [7,8
&&
] that are an
important source of antimicrobial peptides in the
intestine [9] and by a dysregulation of proinflam-
matory cytokines [10
&&
,11] and of innate lymphoid
cells [12
&&
]. This article will focus on recent studies
implicating the role of intestinal bacteria in regulat-
ing immune responses in SpA patients.
Intestinal dysbiosis in patients with
spondyloarthritis
Intestinal dysbiosis has been demonstrated in
patients with SpA with different results in different
subsets. In psoriatic arthritis (PsA), a lower relative
abundance of multiple intestinal bacteria and, in
particular, of beneficial taxa, such as Akkermansia,
Ruminococcus, and Pseudobutyrivibrio has been
demonstrated. These changes are associated with
an increase in secreted IgA and decrease in receptor
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KEY POINTS
 Intestinal dysbiosis occurs in different subsets of
SpA patients.
 Paneth cells are differentially activated in the gut of
SpA patients.
 Activation and expansion of innate lymphoid cells
characterizes the gut of ankylosing spondylitis.
 Activation and expansion of Th9 cells characterizes the
gut of PsA patients.
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&
].
In enthesitis-related arthritis, a recent study [4
&
]
performed in children demonstrated less Faecalibac-
terium prausnitzii and Lachnospiraceae family, a
statistically significant increase in bifidobacterium
and an abundance of Akkermansia muciniphila.
In ankylosing spondylitis, a decrease in the
Bacteroides-Provotella and Clostridium leptum
groups with an increase in Bifidobacterium has been
observed [5]. Recently, Costello et al. by performing
culture-independent microbial community profil-
ing, demonstrated difference in the gut microbiome
of terminal ileum biopsy specimens between anky-
losing spondylitis patients andhealthy controls. Ileal
microbial communities of patients with ankylosing
spondylitis differed significantly from healthy con-
trols, beingcharacterizedbyhigher abundanceof five
bacteria families: Lachnospiraceae, Veillonellaceae, Pre-
votellaceae, Porphyromonadaceae, and Bacteroidaceae
[6
&&
]. Altogether these findings indicate the presence
of different associative bacterial agents in SpA. In this
regard, further studies are required to specifically
address the role of intestinal dysbiosis in the patho-
genesis of SpA and the influence of host genetics in
changing intestinal microbial composition.Epithelial alterations in the gut of patients
with spondyloarthritis
The intestinal epithelium forms a physical and bio-
chemical barrier to commensal and pathogenic
microorganisms conserving host–microbial inter-
actions and tissue homeostasis [9]. This homeostasis
depends on the capacity of intestinal epithelium in
physically segregating commensal bacteria and inte-
grating microbial signals. Alteration of intestinal
permeability is associated with the passage of viable
resident bacteria from the gastrointestinal tract to
normally sterile tissues such as the mesenteric
lymphnodes, and the translocation of inert particles
and other macromolecules, such as lipopolysacchar-
ide endotoxin, across the intestinal mucosal barrier Copyright © 2016 Wolters Kluwe
1040-8711 Copyright  2016 Wolters Kluwer Health, Inc. All rights rese[9]. Alteration of intestinal permeability has been
demonstrated in patients with ankylosing spondyl-
itis and their first relatives degree [13] and prelimi-
nary data seem to indicate downregulation of the
tight junction proteins occludin, claudin 2 and 4,
and zonula occludens 1 in ankylosing spondylitis
ileum [14]. These alterations of tight junctions are
presumably associated with increased intestinal
levels of zonulin [14]. Zonulin, the only physiologi-
cal modulator of intercellular tight junctions
described, is involved in trafficking of macromol-
ecules and, therefore, in the balance between toler-
ance and immune responses [15]. Zonulin
expression seems to be modulated by intestinal
bacteria and may represent a host response against
bacterial colonization of the small intestine [16].
According to the increased permeability, prelimi-
nary evidences suggest that high serum levels of
lipopolysaccharide and i-fatty acid binding protein
are present in ankylosing spondylitis, significantly
associated with the level of tissue inflammation
[14]. It is not clear, however, whether or not these
alterations are related to specific microorganisms.Role of Paneth cells in modulating intestinal
immune responses
It has been demonstrated that certain secreted anti-
bacterial proteins produced by epithelial cells can
shape the composition of intestinal microbial com-
munities. For example, a-defensins small (2–3kD)
antibacterial peptides secreted by Paneth cells have
been proved to modify overall community compo-
sition in mice [17]. Paneth cells are highly special-
ized epithelial cells of the small intestine. They are
located just below the intestinal stem cells in the
crypts of Lieberku¨hn and display large eosinophilic
refractile granules that occupy most of their cyto-
plasm. These granules contain several antimicrobial
compounds and other compounds that are known
to be important in immunity, in themaintenance of
crypt sterility and regulating the balance with col-
onizingmicrobiota and enteric pathogens [18]. Pan-
eth cells have been also demonstrated to participate
in the regulation of several pathways of innate and
adaptive immunity, including that of IL-23/IL-17
axis [18]. In the presence of bacteria or bacterial
antigens, Paneth cells secrete these peptides into
the lumen of the crypts of Lieberku¨hn, thereby
contributing to maintenance of the gastrointestinal
barrier. Paneth cells seem also to be important in the
regulation of intestinal inflammation as seen in ileal
Crohn’s disease that seems to be a specific disorder
of Paneth cells [19]. Homozygosity for the highly
prevalent ATG16L1 risk allele causes Paneth cell
dysfunction and deletion of the unfolded proteinr Health, Inc. All rights reserved.
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Spondyloarthropathiesresponse (UPR) transcription factor X-box binding
protein-1 in intestinal epithelial cells, results in
endoplasmic reticulum (ER) stress, Paneth cells
impairment, and spontaneous enteritis [19]. Paneth
cells are activated in the gut of patients with SpA and
produce different cytokines in different subsets of
SpA. In ankylosing spondylitis, Paneth cells are
activated, produce high levels of antimicrobial pep-
tides, such as a-defensin 5, phospholipase A2, and
lysozime [7] and are an important source of IL-23
[10
&&
], a key cytokine involved in the pathogenesis
of disease, and of IL-32 a cytokine produced in
response to bacterial products (Fig. 1) [19,20]. In
patients with PsA, a hyperplasia of activated Paneth
cells is present, as suggested by the increased levels
of antimicrobial peptides such as a-defensin 5
present in the inflamed ileum [8
&&
]. Differently from
ankylosing spondylitis, in PsA gut Paneth cells are
characterized by the expression of IL-9 and not of IL-
23 (Fig. 2) [8
&&
]. IL-9 is a cytokine initially purified Copyright © 2016 Wolters Kluwer 
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FIGURE 1. Intestinal dysbiosis and immune responses in ankylo
alterations of intestinal permeability and over-expression of IL-23 t
cells (ILC3s). ILC3 may recirculate in the sites of inflammation of a
354 www.co-rheumatology.comand characterized as a T and mast cell growth factor
that impairs intestinal barrier function and prevents
mucosal wound healing in vivo [21
&&
]. Interestingly,
in PsA gut Paneth cells also express the specific IL-9
receptor and the stimulation of isolated epithelial
cells with IL-9 upregulates the expression of the
antimicrobial peptides a-defensin 5 and of cyto-
kines, such as IL-23 and IL-9, suggesting the possib-
ility of a functional autocrine loop involving IL-9/
IL-9R (Fig. 2) [8
&&
]. According to the studies dis-
cussed below, Paneth cells seem to play a funda-
mental role in regulating innate intestinal immune
responses, presumably in response to altered micro-
biota in SpA patients.Autophagy and unfolded protein response in
spondyloarthritis gut
In the context of Paneth cells, the innate pathway of
autophagy senses microbial products to activateHealth, Inc. All rights reserved.
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o
ainflammatory processes and, concomitantly, inter-
act with cellular stress responses such as the UPR
[22]. Impairment in either UPR or autophagy func-
tion in Paneth cells results in each other’s compen-
satory engagement, with development of severe
spontaneous Crohn’s disease-like transmural ileitis
if both mechanisms are compromised [19]. Unre-
solved ER stress, in response to HLA-B27misfolding,
has been observed in the gut of HLA-B27 transgenic
rats but not in HLA-B27 ankylosing spondylitis
patients, in which, however, some studies [23–25]
indicate the occurrence of ER stress in peripheral
blood mononuclear cells/monocytes. In ankylosing
spondylitis in HLA-B27misfolding seems to occur as
demonstrated by the intracellular colocalization of
SYVN1 and free heavy chains (amarker of active free
heavy chains misfolding) [26
&&
]. Despite the pres-
ence of HLA-B27 misfolding, there was not, how-
ever, a significant overexpression of UPR genes.
Differently from UPR, upregulation of the genes
involved in the autophagy pathway is present in
the gut of ankylosing spondylitis patients, mainly
characterized by an increased expression of LC3II,
ATG5, and ATG12 [27]. In particular, LC3II a marker
of ongoing autophagy, is expressed among infiltrat-
ingmononuclear cells and Paneth cells, colocalizing
with ATG5. Further, autophagy but not UPR was
required to modulate the expression of IL-23 in
isolated LPMCs of ankylosing spondylitis patients
with chronic gut inflammation [26
&&
]. Autophagy Copyright © 2016 Wolters Kluwe
1040-8711 Copyright  2016 Wolters Kluwer Health, Inc. All rights reseactivation seems to be a tissue-specific process in
ankylosing spondylitis, since that activation of
autophagy has been not confirmed in the peripheral
blood and synovial tissues in ankylosing spondylitis
patients [27].Innate immune responses in the gut of
spondyloarthritis
Innate immune activation occurs in the gut of SpA
patients as demonstrated by the aberrant expression
of cytokines and expansion of specific subset of
innate cells. Nucleotide-binding oligomerization
domain-containing protein 2 (Nod2) has been
extensively characterized as a bacterial sensor that
induces an antimicrobial and inflammatory gene
expression program [28]. In humans, activation of
monocytes via NOD2 (by its ligand muramyl dipep-
tide) induced differentiation of dendritic cells,
which is dependent on an IL-32-dependent mech-
anism [20]. IL-32 is a recently described cytokine
that has been thought to be a proinflammatory
player because of its capacity to induce the matu-
ration and activation of dendritic cells and the
production of T helper (Th)1 and Th17-polarizing
cytokines via a phospholipase C/c-Jun N-terminal
kinase/nuclear factor-kappaB-dependent pathway
[29]. IL-32 is constitutively expressed in epithelial
cells of colon mucosa and stimulated by IL-1b,
IFN-g, and TNF-a and synergizes with nucleotider Health, Inc. All rights reserved.
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Spondyloarthropathiesoligomerization domain (NOD)1 and NOD2 ligands
for IL-1b and IL-6 production, thus acting as a
proinflammatory cytokine [30]. IL-32 is strongly
upregulated in the inflamed ileum of ankylosing
spondylitis patients at both mRNA and protein
levels. In particular, IL-32 is intensely expressed in
the context of Paneth cells, among endothelial cells
of lamina propria vessels, in the inflammatory infil-
trates (where Crohn’s disease 68þ cells were the
major cellular source) and in the germinal centers
of gut-associated lymphoid tissues in both ankylos-
ing spondylitis and Crohn’s disease patients. Inter-
estingly, in ankylosing spondylitis IL-32 expression is
correlated with IL-10 levels and the in-vitro exposure
of intestinal epithelial cell lines to IL-32 determined
an increased IL-10 production [11]. These findings
suggest that in ankylosing spondylitis, IL-32 partici-
pates in epithelial tissue protective responses in
which the production of IL-10 and antimicrobial
peptides could be the main actors (Fig. 1).
To prevent the translocation of commensals
and/or pathogenic microorganisms across the epi-
thelial barrier, the intestinal tract is equipped with a
highly complex intrinsic immune system that
includes tissue-specific organized lymphoid struc-
tures, such as Peyer’s patches, cryptopatches, and
isolated lymphoid follicles [31,32]. Isolated lym-
phoid follicles formation is induced postnatally by
commensal microbiota and requires cryptopatches.
Cryptopatches are lymphoid structures containing
lymphoid tissue inducer (LTi) cells, a distinct popu-
lation of group 3 innate lymphoid cells [33
&&
,34]. In
response to microbiota signals, intestinal epithelial
cells produce IL-7 that signals via the IL-7 receptor
on LTi cells to induce the expression of lympho-
toxin a1b2 (LT-a1b2) [33
&&
,34,35] that acts in turn
on resident lymphoid tissue organizer cells,
upregulating the expression of chemokines (e.g.
CXCL13, CCL19, and CCL21) and adhesion mol-
ecules (e.g. VCAM1 and ICAM1) required for the
recruitment and retention of lymphocytes into the
cryptopatches [35]. In the inflamed gut of ankylos-
ing spondylitis patients IL-7 is overexpressed,
especially in the context of Paneth cells, and aggre-
gates of LTi cells (CD3c-kitþ/IL-7Rþ) resembling
cryptopatches are present in close proximity of
the bottom of intestinal crypts (Fig. 1) [12
&&
]. Cryp-
topatches seem to be absent in normal ileal samples
suggesting that, in physiological conditions, they
may exist only during a small window of time just
after birth or, alternatively, that they need bacterial
stimulation to develop. The important role of intes-
tinal epithelial cells in modulating the behavior of
LTi cells is also suggested by the ability of isolated
epithelial cells from the gut of ankylosing spondy-
litis to induce the differentiation of type III ILCs Copyright © 2016 Wolters Kluwer 
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&&
]. ILCs are different populations of cells with
lymphoid characteristics but without rearrange-
ment of antigen receptors, mainly distinguished
into three groups: IFN-g-producing ILC1 cells, T
helper type 2 cytokines producing ILC2 cells, and
IL-17 and IL-22 producing ILC3 cells that are associ-
ated with the gastrointestinal mucosa [34]. It has
been recently demonstrated that ILC3 expressmajor
histocompatibility complex class II (MHCII), sim-
ilarly to thymic epithelial cells, and that MHCII(þ)
ILC3s directly induce cell death of activated com-
mensal bacteria-specific T cells. MHCII on colonic
ILC3s has been demonstrated to be reduced in
pediatric inflammatory bowel disease patients
suggesting that this selection pathway for commen-
sal bacteria-specific CD4(þ) T cells is dysregulated in
human inflammatory bowel disease [36
&&
]. In anky-
losing spondylitis patients, ILC3 are expanded in
the gut and characterized by the high expression of
IL-17 and IL-22 and of the transcription factor T-bet
(Fig. 1) [12
&&
]. Absence of RAR-related orphan recep-
tor C in ankylosing spondylitis intestinal ILC3 could
be related to a specific stage of differentiation of
these cells as it has been demonstrated that ILC3s
may follow a differentiation program in which they
first upregulate T-bet, then acquire natural cytotoxic
receptors and then downregulate RORgt, indicating
phenotypic and functional plasticity [34]. It is not
possible to confirm that different subsets of ILC3s
producing different cytokines may act promoting
different innate immune responses. It seems reason-
able, however, that ILC3s producing IL-22 might be
involved in tissue protective responses such as the
induction of goblet cells hyperplasia and increased
mucins production, observed in ankylosing spondy-
litis gut. Conversely, IL-17 and IL-17/IL-22-produc-
ing cells might be involved in eliciting
proinflammatory activities. ILC3s have been also
demonstrated to be expanded in the peripheral
blood, synovial fluids, and bone marrow of ankylos-
ing spondylitis patients and to express the intestinal
homing integrin a4b7 (Fig. 1) [12
&&
]. In addition,
MAdCAM1, the a4b7 ligand, was found to be highly
represented in the high endothelial venules of the
gut and in the inflamed bone marrow (BM) of anky-
losing spondylitis, suggesting that a recirculation of
ILC3 between the gut and the BM occurs. In light of
this evidence, modulation of ILC3s might be con-
sidered as a therapeutic strategy in ankylosing spon-
dylitis. In this regard, antitumor necrosis factor
therapy resulted in ankylosing spondylitis in the
reduction of ILC3 at both systemic and gut level
and in a strong reduced expression of MAdCAM1 in
ileal samples [12
&&
], indicating that therapeutic
modulation of ILC3 may be beneficial in ankylosing
spondylitis.Health, Inc. All rights reserved.
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spondyloarthritis patients
Different immune polarization is present in anky-
losing spondylitis and PsA gut. In ankylosing
spondylitis patients, despite IL-23 overexpression,
a clear Th17 and Th1 polarization is lacking [10
&&
].
Conversely, subclinical gut inflammation of PsA
patients is characterized by clear Th17 and Th22
polarized immune responses [8
&&
]. Unlike ankylos-
ing spondylitis, a strong and significant upregula-
tion of IL-9 immunologically was observed in PsA
gut, mainly expressed by Th9 cells and high endo-
thelial venules [8
&&
]. Th9 subset of helper T cells
has been demonstrated to serve an important role
in driving intestinal inflammation in ulcerative
colitis [37
&
] and the significant expansion we
observed in PsA patients may indicate a role for
these cells also in PsA gut inflammation (Fig. 2).
Th9 are expanded also in the peripheral blood and
in synovial tissues of PsA and express a4b7þ
indicating the intestinal origin of these cells
(Fig. 2) [8
&&
]. These findings may suggest a different
immune polarization in the gut of ankylosing spon-
dylitis vs. PsA patients. Whether these alterations
are driven by the different microbiota remains,
however, to be elucidated.CONCLUSION
Intestinal dysbiosis is present in SpA patients and is
associatedwith alterations of intestinal permeability
and extensive activation of innate and adaptive
immunity. Modulation of microbiota and/or of
innate immune responses may warrant future thera-
peutic strategies in SpA.
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